Deacetylation-dependent regulation of PARP1 by SIRT2 dictates ubiquitination of PARP1 in oxidative stress-induced vascular injury
Poly(ADP-ribose) polymerase 1 (PARP1) has a major regulatory role in cardiovascular disease. However, inhibiting PARP1 activity does not significantly improve clinical outcomes of cardiovascular disease, which suggests that the regulatory mechanism of PARP1 in cardiovascular disease is unclear. Here...
Main Authors: | Naijin Zhang, Ying Zhang, Boquan Wu, Shaojun Wu, Shilong You, Saien Lu, Jingwei Liu, Xinyue Huang, Jiaqi Xu, Liu Cao, Yingxian Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-11-01
|
Series: | Redox Biology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213231721003001 |
Similar Items
-
Antagonistic crosstalk between SIRT1, PARP-1, and -2 in the regulation of chronic inflammation associated with aging and metabolic diseases
by: Hun Taeg Chung, et al.
Published: (2014-12-01) -
Silencing of PARP2 Blocks Autophagic Degradation
by: Laura Jankó, et al.
Published: (2020-02-01) -
Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells
by: Paulina Gil-Kulik, et al.
Published: (2020-05-01) -
PARP1 in Carcinomas and PARP1 Inhibitors as Antineoplastic Drugs
by: Luyao Wang, et al.
Published: (2017-10-01) -
Revealing the selective mechanisms of inhibitors to PARP-1 and PARP-2 via multiple computational methods
by: Hongye Hu, et al.
Published: (2020-05-01)